MicroRNAs as pharmacological targets in diabetes

Pharmacological Research

Volumn 75, Issue , 2013, Pages 37-47

  Mao, Yiping ^a   Mohan, Ramkumar ^a   Zhang, Shungang ^a   Tang, Xiaoqing ^a  

^a MICHIGAN TECHNOLOGICAL UNIVERSITY   (United States)

Author keywords

Diabetes; Insulin resistance; MicroRNAs; miRNA therapeutics

Indexed keywords

ACETYLSALICYLIC ACID; ANTAGOMIR 122; ANTIDIABETIC AGENT; EXENDIN 4; INSULIN; LOCKED NUCLEIC ACID ANTIMICRORNA; LOCKED NUCLEIC ACID ANTIMICRORNA 122; MICRORNA; MICRORNA 103; MICRORNA 107; MICRORNA 122; MICRORNA 124A; MICRORNA 126; MICRORNA 143; MICRORNA 181A; MICRORNA 181A BLOCKING AGENT; MICRORNA 21; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; MICRORNA 30D; MICRORNA 320; MICRORNA 338 3P; MICRORNA 375; MICRORNA 7; MICRORNA 802; MICRORNA 9; MORPHOLINO OLIGONUCLEOTIDE; MYOMICRORNA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADIPOSE TISSUE; ANTICOAGULATION; ANTIDIABETIC ACTIVITY; ARTICLE; BINDING AFFINITY; BLOOD LEVEL; CANCER DIAGNOSIS; CANCER PROGNOSIS; CELL FUNCTION; CELL SURVIVAL; CHOLESTEROL METABOLISM; CYTOKINE RELEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE MARKER; DRUG BINDING; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE UTILIZATION; HEART DISEASE; HEART FAILURE; HORMONE ACTION; HUMAN; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; LIPID METABOLISM; LIVER; LIVER TOXICITY; MICRORNA BLOOD LEVEL; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; ORGANOGENESIS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN FUNCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; UNSPECIFIED SIDE EFFECT;

DIABETES; INSULIN RESISTANCE; MICRORNAS; MIRNA THERAPEUTICS;

ADIPOSE TISSUE; ANIMALS; BRAIN; DIABETES MELLITUS; GENE EXPRESSION REGULATION; GENE TARGETING; GLUCOSE; HUMANS; INSULIN; LIPID METABOLISM; LIVER; MICRORNAS; MUSCLE, SKELETAL; RNA, MESSENGER;

EID: 84884820730     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.06.005     Document Type: Review

References (152)

1. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2009 215 233
2. J.A. Broderick, and P.D. Zamore MicroRNA therapeutics Gene Therapy 18 2011 1104 1110
3. H.R. Chiang, L.W. Schoenfeld, J.G. Ruby, V.C. Auyeung, N. Spies, and D. Baek Mammalian microRNAs: experimental evaluation of novel and previously annotated genes Genes and Development 24 2010 992 1009
4. A. Barker, C. Langenberg, and N.J. Wareham Genetic determinants of glucose homeostasis Best Practice & Research Clinical Endocrinology & Metabolism 26 2012 159 170
5. A.R. Saltiel, and C.R. Kahn Insulin signalling and the regulation of glucose and lipid metabolism Nature 414 2001 799 806 (Pubitemid 34000783)
6. B. Goke Islet cell function: alpha and beta cells - partners towards normoglycaemia International Journal of Clinical Practice Supplement 159 2008 2 7 (Pubitemid 351229610)
7. K. Cusi The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes Current Diabetes Reports 10 2010 306 315
8. E. Kugelberg Diabetes: Betatrophin-inducing beta-cell expansion to treat diabetes mellitus? Nature Reviews Endocrinology 9 2013 379
9. P. Yi, J.S. Park, and D.A. Melton Betatrophin: a hormone that controls pancreatic beta cell proliferation Cell 153 2013 747 758
10. K. Uno, H. Katagiri, T. Yamada, Y. Ishigaki, T. Ogihara, and J. Imai Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity Science 312 2006 1656 1659 (Pubitemid 43902665)
11. J. Imai, H. Katagiri, T. Yamada, Y. Ishigaki, T. Suzuki, and H. Kudo Regulation of pancreatic beta cell mass by neuronal signals from the liver Science 322 2008 1250 1254
12. A. El Ouaamari, D. Kawamori, E. Dirice, C.W. Liew, J.L. Shadrach, and J. Hu Liver-derived systemic factors drive beta cell hyperplasia in insulin-resistant states Cell Reports 3 2013 401 410
13. A. Avogaro, C. Giorda, M. Maggini, E. Mannucci, R. Raschetti, and F. Lombardo Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location Diabetes Care 30 2007 1241 1247 (Pubitemid 46684654)
14. M. Happich, L. Breitscheidel, C. Meisinger, M. Ulbig, P. Falkenstein, and U. Benter Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study Current Medical Research and Opinion 23 2007 1367 1374 (Pubitemid 46998445)
15. G. De Mattia, M.C. Bravi, O. Laurenti, A. Moretti, R. Cipriani, and A. Gatti Endothelial dysfunction and oxidative stress in type 1 and type 2 diabetic patients without clinical macrovascular complications Diabetes Research and Clinical Practice 79 2008 337 342
16. K. Connelly, D. Kelly, and R. Gilbert Clinically relevant models of diabetic cardiac complications Circulation Research 101 2007 e78
17. A. Cohen, and E.S. Horton Progress in the treatment of type 2 diabetes: new pharmacologic approaches to improve glycemic control Current Medical Research and Opinion 23 2007 905 917 (Pubitemid 46631494)
18. J.K. Distefano, and R.M. Watanabe Pharmacogenetics of anti-diabetes drugs Pharmaceuticals 3 2010 2610 2646
19. P.A. Carpino, and B. Goodwin Diabetes area participation analysis: a review of companies and targets described in the 2008-2010 patent literature Expert Opinion on Therapeutic Patents 20 2010 1627 1651
20. M.N. Poy, L. Eliasson, J. Krutzfeldt, S. Kuwajima, X. Ma, and P.E. Macdonald A pancreatic islet-specific microRNA regulates insulin secretion Nature 432 2004 226 230 (Pubitemid 39545853)
21. W.P. Kloosterman, A.K. Lagendijk, R.F. Ketting, J.D. Moulton, and R.H. Plasterk Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development PLoS Biology 5 2007 e203
22. N. Baroukh, M.A. Ravier, M.K. Loder, E.V. Hill, A. Bounacer, and R. Scharfmann MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines Journal of Biological Chemistry 282 2007 19575 19588 (Pubitemid 47100119)
23. M.N. Poy, M. Spranger, and M. Stoffel microRNAs and the regulation of glucose and lipid metabolism Diabetes, Obesity and Metabolism 9 Suppl. 2 2007 67 73 (Pubitemid 47543128)
24. J. Xiao, X. Luo, H. Lin, Y. Zhang, Y. Lu, and N. Wang MicroRNA miR-133 represses HERG K+ channel expression contributing to QT prolongation in diabetic hearts Journal of Biological Chemistry 282 2007 12363 12367 (Pubitemid 47100573)
25. M. Kato, J. Zhang, M. Wang, L. Lanting, H. Yuan, and J.J. Rossi MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors Proceedings of the National Academy of Sciences of the United States of America 104 2007 3432 3437 (Pubitemid 46364176)
26. M.N. Poy, J. Hausser, M. Trajkovski, M. Braun, S. Collins, and P. Rorsman miR-375 maintains normal pancreatic alpha- and beta-cell mass Proceedings of the National Academy of Sciences of the United States of America 106 2009 5813 5818
27. E. Roggli, S. Gattesco, D. Caille, C. Briet, C. Boitard, and P. Meda Changes in microRNA expression contribute to pancreatic beta-cell dysfunction in prediabetic NOD mice Diabetes 61 2012 1742 1751
28. E. Roggli, A. Britan, S. Gattesco, N. Lin-Marq, A. Abderrahmani, and P. Meda Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells Diabetes 59 2010 978 986
29. X. Zhao, R. Mohan, S. Ozcan, and X. Tang MicroRNA-30d induces insulin transcription factor MafA and insulin production by targeting mitogen-activated protein 4 kinase 4 (MAP4K4) in pancreatic beta-cells Journal of Biological Chemistry 287 2012 31155 31164
30. S. Erener, M. Mojibian, J.K. Fox, H.C. Denroche, and T.J. Kieffer Circulating miR-375 as a biomarker of beta-cell death and diabetes in mice Endocrinology 154 2013 603 608
31. H. Zhao, J. Guan, H.M. Lee, Y. Sui, L. He, and J.J. Siu Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition Pancreas 39 2010 843 846
32. S.L. Fernandez-Valverde, R.J. Taft, and J.S. Mattick MicroRNAs in beta-cell biology, insulin resistance, diabetes and its complications Diabetes 60 2011 1825 1831
33. S.S. Andrali, M.L. Sampley, N.L. Vanderford, and S. Ozcan Glucose regulation of insulin gene expression in pancreatic beta-cells Biochemical Journal 415 2008 1 10
34. F.C. Lynn, P. Skewes-Cox, Y. Kosaka, M.T. McManus, B.D. Harfe, and M.S. German MicroRNA expression is required for pancreatic islet cell genesis in the mouse Diabetes 56 2007 2938 2945 (Pubitemid 350223628)
35. B.R. Gauthier, and C.B. Wollheim MicroRNAs: 'ribo-regulators' of glucose homeostasis Nature Medicine 12 2006 36 38 (Pubitemid 43050057)
36. C. Guay, E. Roggli, V. Nesca, C. Jacovetti, and R. Regazzi Diabetes mellitus, a microRNA-related disease? Translational Research 157 2011 253 264
37. X. Tang, G. Tang, and S. Ozcan Role of microRNAs in diabetes Biochimica et Biophysica Acta 1779 2008 697 701
38. A. El Ouaamari, N. Baroukh, G.A. Martens, P. Lebrun, D. Pipeleers, and E. van Obberghen miR-375 targets 3′-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells Diabetes 57 2008 2708 2717
39. T. Avnit-Sagi, L. Kantorovich, S. Kredo-Russo, E. Hornstein, and M.D. Walker The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas PLoS One 4 2009 e5033
40. T. Avnit-Sagi, T. Vana, and M.D. Walker Transcriptional mechanisms controlling miR-375 gene expression in the pancreas Experimental Diabetes Research 2012 2012 891216
41. D.M. Keller, S. McWeeney, A. Arsenlis, J. Drouin, C.V. Wright, and H. Wang Characterization of pancreatic transcription factor Pdx-1 binding sites using promoter microarray and serial analysis of chromatin occupancy Journal of Biological Chemistry 282 2007 32084 32092 (Pubitemid 350106424)
42. M.V. Joglekar, V.M. Joglekar, and A.A. Hardikar Expression of islet-specific microRNAs during human pancreatic development Gene Expression Patterns 9 2009 109 113
43. R. Wei, J. Yang, G.Q. Liu, M.J. Gao, W.F. Hou, and L. Zhang Dynamic expression of microRNAs during the differentiation of human embryonic stem cells into insulin-producing cells Gene 518 2013 246 255
44. L. Kong, J. Zhu, W. Han, X. Jiang, M. Xu, and Y. Zhao Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study Acta Diabetologica 48 2011 61 69
45. V. Bravo-Egana, S. Rosero, R.D. Molano, A. Pileggi, C. Ricordi, and J. Dominguez-Bendala Quantitative differential expression analysis reveals miR-7 as major islet microRNA Biochemical and Biophysical Research Communications 366 2008 922 926
46. M. Correa-Medina, V. Bravo-Egana, S. Rosero, C. Ricordi, H. Edlund, and J. Diez MicroRNA miR-7 is preferentially expressed in endocrine cells of the developing and adult human pancreas Gene Expression Patterns 9 2009 193 199
47. S. Kredo-Russo, A. Ness, A.D. Mandelbaum, M.D. Walker, and E. Hornstein Regulation of pancreatic microRNA-7 expression Experimental Diabetes Research 2012 2012 695214
48. S. Kredo-Russo, A.D. Mandelbaum, A. Ness, I. Alon, K.A. Lennox, and M.A. Behlke Pancreas-enriched miRNA refines endocrine cell differentiation Development 139 2012 3021 3031
49. C.H. Chung, and F. Levine Adult pancreatic alpha-cells: a new source of cells for beta-cell regeneration The Review of Diabetic Studies 7 2010 124 131
50. P. Collombat, X. Xu, P. Ravassard, B. Sosa-Pineda, S. Dussaud, and N. Billestrup The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells Cell 138 2009 449 462
51. S. Bonner-Weir, W.C. Li, L. Ouziel-Yahalom, L. Guo, G.C. Weir, and A. Sharma Beta-cell growth and regeneration: replication is only part of the story Diabetes 59 2010 2340 2348
52. Y. Wang, J. Liu, C. Liu, A. Naji, and D.A. Stoffers MicroRNA-7 regulates the mTOR pathway and proliferation in adult pancreatic beta-cells Diabetes 62 2013 887 895
53. T.J. Pullen, G. da Silva Xavier, G. Kelsey, and G.A. Rutter miR-29a and miR-29b contribute to pancreatic beta-cell-specific silencing of monocarboxylate transporter 1 (Mct1) Molecular and Cellular Biology 31 2011 3182 3194
54. R. Zhou, G. Hu, A.Y. Gong, and X.M. Chen Binding of NF-kappaB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells Nucleic Acids Research 38 2010 3222 3232
55. F. Allagnat, D. Cunha, F. Moore, J.M. Vanderwinden, D.L. Eizirik, and A.K. Cardozo Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to beta-cell apoptosis Cell Death and Differentiation 18 2011 328 337
56. T. Otonkoski, N. Kaminen, J. Ustinov, R. Lapatto, T. Meissner, and E. Mayatepek Physical exercise-induced hyperinsulinemic hypoglycemia is an autosomal-dominant trait characterized by abnormal pyruvate-induced insulin release Diabetes 52 2003 199 204 (Pubitemid 36042127)
57. P. Lovis, E. Roggli, D.R. Laybutt, S. Gattesco, J.Y. Yang, and C. Widmann Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction Diabetes 57 2008 2728 2736
58. V. Bravo-Egana, S. Rosero, D. Klein, Z. Jiang, N. Vargas, and N. Tsinoremas Inflammation-mediated regulation of microRNA expression in transplanted pancreatic islets Journal of Transplantation 2012 2012 723614
59. K. Fujimoto, T. Shibasaki, N. Yokoi, Y. Kashima, M. Matsumoto, and T. Sasaki Piccolo, a Ca2+ sensor in pancreatic beta-cells. Involvement of cAMP-GEFII.Rim2. Piccolo complex in cAMP-dependent exocytosis Journal of Biological Chemistry 277 2002 50497 50502 (Pubitemid 36042206)
60. Q. Ruan, T. Wang, V. Kameswaran, Q. Wei, D.S. Johnson, and F. Matschinsky The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death Proceedings of the National Academy of Sciences of the United States of America 108 2011 12030 12035
61. S. Matsumoto, M. Takita, D. Chaussabel, H. Noguchi, M. Shimoda, and K. Sugimoto Improving efficacy of clinical islet transplantation with iodixanol-based islet purification, thymoglobulin induction, and blockage of IL-1beta and TNF-alpha Cell Transplantation 20 2011 1641 1647
62. D. Bonci MicroRNA-21 as therapeutic target in cancer and cardiovascular disease Recent Patents on Cardiovascular Drug Discovery 5 2010 156 161
63. Y. Cheng, P. Zhu, J. Yang, X. Liu, S. Dong, and X. Wang Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4 Cardiovascular Research 87 2010 431 439
64. S. Roy, S. Khanna, S.R. Hussain, S. Biswas, A. Azad, and C. Rink MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue Cardiovascular Research 82 2009 21 29
65. T. Thum, C. Gross, J. Fiedler, T. Fischer, S. Kissler, and M. Bussen MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Nature 456 2008 980 984
66. A. Zampetaki, S. Kiechl, I. Drozdov, P. Willeit, U. Mayr, and M. Prokopi Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes Circulation Research 107 2010 810 817
67. V. Plaisance, A. Abderrahmani, V. Perret-Menoud, P. Jacquemin, F. Lemaigre, and R. Regazzi MicroRNA-9 controls the expression of Granuphilin/Slp4 and the secretory response of insulin-producing cells Journal of Biological Chemistry 281 2006 26932 26942 (Pubitemid 44401722)
68. D. Ramachandran, U. Roy, S. Garg, S. Ghosh, S. Pathak, and U. Kolthur-Seetharam Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic beta-islets FEBS Journal 278 2011 1167 1174
69. L. Bordone, M.C. Motta, F. Picard, A. Robinson, U.S. Jhala, and J. Apfeld Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells PLoS Biology 4 2006 e31
70. J.H. Lee, M.Y. Song, E.K. Song, E.K. Kim, W.S. Moon, and M.K. Han Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway Diabetes 58 2009 344 351
71. M.V. Joglekar, V.S. Parekh, and A.A. Hardikar New pancreas from old: microregulators of pancreas regeneration Trends in Endocrinology & Metabolism 18 2007 393 400 (Pubitemid 350137766)
72. N.N. Baroukh, and E. Van Obberghen Function of microRNA-375 and microRNA-124a in pancreas and brain FEBS Journal 276 2009 6509 6521
73. P. Lovis, S. Gattesco, and R. Regazzi Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs Biological Chemistry 389 2008 305 312 (Pubitemid 351329024)
74. T. Melkman-Zehavi, R. Oren, S. Kredo-Russo, T. Shapira, A.D. Mandelbaum, and N. Rivkin miRNAs control insulin content in pancreatic beta-cells via downregulation of transcriptional repressors EMBO Journal 30 2011 835 845
75. X. Tang, L. Muniappan, G. Tang, and S. Ozcan Identification of glucose-regulated miRNAs from pancreatic {beta} cells reveals a role for miR-30d in insulin transcription RNA 15 2009 287 293
76. K. Bouzakri, P. Ribaux, and P.A. Halban Silencing mitogen-activated protein 4 kinase 4 (MAP4K4) protects beta cells from tumor necrosis factor-alpha-induced decrease of IRS-2 and inhibition of glucose-stimulated insulin secretion Journal of Biological Chemistry 284 2009 27892 27898
77. T. Sartorius, H. Staiger, C. Ketterer, M. Heni, F. Machicao, and A. Guilherme Association of common genetic variants in the MAP4K4 locus with prediabetic traits in humans PLoS ONE 7 2012 e47647
78. H. Kaneto, T. Miyatsuka, Y. Fujitani, H. Noguchi, K.H. Song, and K.H. Yoon Role of PDX-1 and MafA as a potential therapeutic target for diabetes Diabetes Research and Clinical Practice 77 Suppl. 1 2007 S127 S137
79. H. Kaneto, T.A. Matsuoka, S. Kawashima, K. Yamamoto, K. Kato, and T. Miyatsuka Role of MafA in pancreatic beta-cells Advanced Drug Delivery Reviews 61 2009 489 496
80. M.V. Joglekar, D. Patil, V.M. Joglekar, G.V. Rao, D.N. Reddy, and S. Mitnala The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells Islets 1 2009 137 147
81. S. Ozcan MiR-30 family and EMT in human fetal pancreatic islets Islets 1 2009 283 285
82. C. Jacovetti, A. Abderrahmani, G. Parnaud, J.C. Jonas, M.L. Peyot, and M. Cornu MicroRNAs contribute to compensatory beta cell expansion during pregnancy and obesity The Journal of Clinical Investigation 122 2012 3541 3551
83. C. Esau, X. Kang, E. Peralta, E. Hanson, E.G. Marcusson, and L.V. Ravichandran MicroRNA-143 regulates adipocyte differentiation Journal of Biological Chemistry 279 2004 52361 52365 (Pubitemid 39656612)
84. I. Guller, and A.P. Russell MicroRNAs in skeletal muscle: their role and regulation in development, disease and function Journal of Physiology 588 2010 4075 4087
85. R.A. McGregor, and M.S. Choi MicroRNAs in the regulation of adipogenesis and obesity Current Molecular Medicine 11 2011 304 316
86. Z. Yang, C. Bian, H. Zhou, S. Huang, S. Wang, and L. Liao MicroRNA hsa-miR-138 inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells through adenovirus EID-1 Stem Cells and Development 20 2011 259 267
87. R. Takanabe, K. Ono, Y. Abe, T. Takaya, T. Horie, and H. Wada Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet Biochemical and Biophysical Research Communications 376 2008 728 732
88. H. Xie, B. Lim, and H.F. Lodish MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity Diabetes 58 2009 1050 1057
89. T. Wang, M. Li, J. Guan, P. Li, H. Wang, and Y. Guo MicroRNAs miR-27a and miR-143 regulate porcine adipocyte lipid metabolism International Journal of Molecular Sciences 12 2011 7950 7959
90. M. Trajkovski, J. Hausser, J. Soutschek, B. Bhat, A. Akin, and M. Zavolan MicroRNAs 103 and 107 regulate insulin sensitivity Nature 474 2011 649 653
91. S.D. Jordan, M. Kruger, D.M. Willmes, N. Redemann, F.T. Wunderlich, and H.S. Bronneke Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism Nature Cell Biology 13 2011 434 446
92. A. He, L. Zhu, N. Gupta, Y. Chang, and F. Fang Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes Molecular Endocrinology 21 2007 2785 2794 (Pubitemid 350035159)
93. B.M. Herrera, H.E. Lockstone, J.M. Taylor, M. Ria, A. Barrett, and S. Collins Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes Diabetologia 53 2010 1099 1109
94. B.M. Herrera, H.E. Lockstone, J.M. Taylor, Q.F. Wills, P.J. Kaisaki, and A. Barrett MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes BMC Medical Genomics 2 2009 54
95. S.Y. Park, J.H. Lee, M. Ha, J.W. Nam, and V.N. Kim miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42 Nature Structural & Molecular Biology 16 2009 23 29
96. J. Long, Y. Wang, W. Wang, B.H. Chang, and F.R. Danesh MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy Journal of Biological Chemistry 286 2011 11837 11848
97. H.Y. Ling, H.S. Ou, S.D. Feng, X.Y. Zhang, Q.H. Tuo, and L.X. Chen Changes in microRNA (miR) profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes Clinical and Experimental Pharmacology and Physiology 36 2009 e32 e39
98. X.H. Wang, R.Z. Qian, W. Zhang, S.F. Chen, H.M. Jin, and R.M. Hu MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats Clinical and Experimental Pharmacology and Physiology 36 2009 181 188
99. J.F. Chen, E.M. Mandel, J.M. Thomson, Q. Wu, T.E. Callis, and S.M. Hammond The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation Nature Genetics 38 2006 228 233 (Pubitemid 43177239)
100. N. Liu, A.H. Williams, Y. Kim, J. McAnally, S. Bezprozvannaya, and L.B. Sutherland An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133 Proceedings of the National Academy of Sciences of the United States of America 104 2007 20844 20849
101. A. Granjon, M.P. Gustin, J. Rieusset, E. Lefai, E. Meugnier, and I. Guller The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway Diabetes 58 2009 2555 2564
102. I.J. Gallagher, C. Scheele, P. Keller, A.R. Nielsen, J. Remenyi, and C.P. Fischer Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes Genome Medicine 2 2010 9
103. S. Nielsen, C. Scheele, C. Yfanti, T. Akerstrom, A.R. Nielsen, and B.K. Pedersen Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle Journal of Physiology 588 2010 4029 4037
104. Z.X. Shan, Q.X. Lin, C.Y. Deng, J.N. Zhu, L.P. Mai, and J.L. Liu miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes FEBS Letters 584 2010 3592 3600
105. H. Yin, A. Pasut, V.D. Soleimani, C.F. Bentzinger, G. Antoun, and S. Thorn MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16 Cell Metabolism 17 2013 210 224
106. P. Seale, B. Bjork, W. Yang, S. Kajimura, S. Chin, and S. Kuang PRDM16 controls a brown fat/skeletal muscle switch Nature 454 2008 961 967
107. P. Seale, S. Kajimura, W. Yang, S. Chin, L.M. Rohas, and M. Uldry Transcriptional control of brown fat determination by PRDM16 Cell Metabolism 6 2007 38 54 (Pubitemid 47008902)
108. C.J. Ramnanan, D.S. Edgerton, G. Kraft, and A.D. Cherrington Physiologic action of glucagon on liver glucose metabolism Diabetes, Obesity and Metabolism 13 Suppl. 1 2011 118 125
109. I.P. Pogribny, and F.A. Beland Role of microRNAs in the regulation of drug metabolism and disposition genes in diabetes and liver disease Expert Opinion on Drug Metabolism & Toxicology 9 2013 713 724
110. N. Anderson, and J. Borlak Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis Pharmacological Reviews 60 2008 311 357
111. C. Esau, S. Davis, S.F. Murray, X.X. Yu, S.K. Pandey, and M. Pear miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metabolism 3 2006 87 98
112. S. Li, X. Chen, H. Zhang, X. Liang, Y. Xiang, and C. Yu Differential expression of microRNAs in mouse liver under aberrant energy metabolic status Journal of Lipid Research 50 2009 1756 1765
113. P. Andersson, O. Gidlof, O.O. Braun, M. Gotberg, J. van der Pals, and B. Olde Plasma levels of liver-specific miR-122 is massively increased in a porcine cardiogenic shock model and attenuated by hypothermia Shock 37 2012 234 238
114. F.J. Ortega, J.M. Mercader, V. Catalan, J.M. Moreno-Navarrete, N. Pueyo, and M. Sabater Targeting the circulating MicroRNA signature of obesity Clinical Chemistry 59 2013 781 792
115. S.H. Hsu, B. Wang, J. Kota, J. Yu, S. Costinean, and H. Kutay Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver The Journal of Clinical Investigation 122 2012 2871 2883
116. B. Zhou, C. Li, W. Qi, Y. Zhang, F. Zhang, and J.X. Wu Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity Diabetologia 55 2012 2032 2043
117. L.B. Nielsen, C. Wang, K. Sorensen, C.H. Bang-Berthelsen, L. Hansen, and M.L. Andersen Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression Experimental Diabetes Research 2012 2012 896362
118. J.W. Kornfeld, C. Baitzel, A.C. Konner, H.T. Nicholls, M.C. Vogt, and K. Herrmanns Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b Nature 494 2013 111 115
119. G. Tang, J. Yan, Y. Gu, M. Qiao, R. Fan, and Y. Mao Construction of short tandem target mimic (STTM) to block the functions of plant and animal microRNAs Methods 58 2012 118 125
120. J.J. Rossi New hope for a microRNA therapy for liver cancer Cell 137 2009 990 992
121. P.D. Monroig, and G.A. Calin MicroRNA and epigenetics: diagnostic and therapeutic opportunities Current Pathobiology Reports 1 2013 43 52
122. K.J. Rayner, and E.J. Hennessy Extracellular communication via microRNA: lipid particles have a new message Journal of Lipid Research 54 2013 1174 1181
123. P. Diehl, A. Fricke, L. Sander, J. Stamm, N. Bassler, and N. Htun Microparticles: major transport vehicles for distinct microRNAs in circulation Cardiovascular Research 93 2012 633 644
124. D. Xiao, J. Ohlendorf, Y. Chen, D.D. Taylor, S.N. Rai, and S. Waigel Identifying mRNA, microRNA and protein profiles of melanoma exosomes PloS ONE 7 2012 e46874
125. M. Ferracin, A. Veronese, and M. Negrini Micromarkers: miRNAs in cancer diagnosis and prognosis Expert Review of Molecular Diagnostics 10 2010 297 308
126. E. van Rooij, and E.N. Olson MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles Nature Reviews Drug Discovery 11 2012 860 872
127. E.E. Creemers, A.J. Tijsen, and Y.M. Pinto Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circulation Research 110 2012 483 495
128. X. Ding, J. Ding, J. Ning, F. Yi, J. Chen, and D. Zhao Circulating microRNA-122 as a potential biomarker for liver injury Molecular Medicine Reports 5 2012 1428 1432
129. J.E. Fish, M.M. Santoro, S.U. Morton, S. Yu, R.F. Yeh, and J.D. Wythe miR-126 regulates angiogenic signaling and vascular integrity Developmental Cell 15 2008 272 284
130. S. Wang, A.B. Aurora, B.A. Johnson, X. Qi, J. McAnally, and J.A. Hill The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis Developmental Cell 15 2008 261 271
131. H.C. de Boer, C. van Solingen, J. Prins, J.M. Duijs, M.V. Huisman, and T.J. Rabelink Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease European Heart Journal 2013 Feb 4
132. K. Ishihara, D. Sasaki, K. Tsuruda, N. Inokuchi, K. Nagai, and H. Hasegawa Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia Cancer Epidemiology 36 2012 560 565
133. G. Ren, and Y. Kang A one-two punch of miR-126/126* against metastasis Nature Cell Biology 15 2013 231 233
134. M. Tomasetti, S. Staffolani, L. Nocchi, J. Neuzil, E. Strafella, and N. Manzella Clinical significance of circulating miR-126 quantification in malignant mesothelioma patients Clinical Biochemistry 45 2012 575 581
135. R.J. Bryant, T. Pawlowski, J.W. Catto, G. Marsden, R.L. Vessella, and B. Rhees Changes in circulating microRNA levels associated with prostate cancer British Journal of Cancer 106 2012 768 774
136. C. Zhao, J. Dong, T. Jiang, Z. Shi, B. Yu, and Y. Zhu Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus PLoS ONE 6 2011 e23925
137. D.M. Pereira, P.M. Rodrigues, P.M. Borralho, and C.M. Rodrigues Delivering the promise of miRNA cancer therapeutics Drug Discovery Today 18 2013 282 289
138. B. Vester, and J. Wengel LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA Biochemistry 43 2004 13233 13241 (Pubitemid 39391124)
139. U.A. Orom, S. Kauppinen, and A.H. Lund LNA-modified oligonucleotides mediate specific inhibition of microRNA function Gene 372 2006 137 141
140. S. Putta, L. Lanting, G. Sun, G. Lawson, M. Kato, and R. Natarajan Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy Journal of the American Society of Nephrology (JASN) 23 2012 458 469
141. J. Elmen, M. Lindow, S. Schutz, M. Lawrence, A. Petri, and S. Obad LNA-mediated microRNA silencing in non-human primates Nature 452 2008 896 899 (Pubitemid 351550859)
142. C.G. Liew Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols The Review of Diabetic Studies (RDS) 7 2010 82 92
143. J. Liu, M.P. Ashton, H. Sumer, M.K. O'Bryan, T.C. Brodnicki, and P.J. Verma Generation of stable pluripotent stem cells from NOD mouse tail-tip fibroblasts Diabetes 60 2011 1393 1398
144. K.D. Wilson, S. Venkatasubrahmanyam, F. Jia, N. Sun, A.J. Butte, and J.C. Wu MicroRNA profiling of human-induced pluripotent stem cells Stem Cells and Development 18 2009 749 758
145. N. Pfaff, J. Fiedler, A. Holzmann, A. Schambach, T. Moritz, and T. Cantz miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2 EMBO Reports 12 2011 1153 1159
146. C.S. Yang, Z. Li, and T.M. Rana MicroRNAs modulate iPS cell generation RNA 17 2011 1451 1460
147. I.M. Lorenzo, A. Fleischer, and D. Bachiller Generation of mouse and human induced pluripotent stem cells (iPSC) from primary somatic cells Stem Cell Reviews 2012
148. I.G. Kolfschoten, E. Roggli, V. Nesca, and R. Regazzi Role and therapeutic potential of microRNAs in diabetes Diabetes, Obesity and Metabolism 11 Suppl. 4 2009 118 129
149. A. de Fougerolles, H.P. Vornlocher, J. Maraganore, and J. Lieberman Interfering with disease: a progress report on siRNA-based therapeutics Nature Reviews Drug Discovery 6 2007 443 453 (Pubitemid 47064567)
150. J. Xie, S.L. Ameres, R. Friedline, J.H. Hung, Y. Zhang, and Q. Xie Long-term, efficient inhibition of microRNA function in mice using rAAV vectors Nature Methods 9 2012 403 409
151. S.Q. Wu, Z.Z. Xu, J. Lin, and R. Zhan Construction of miRNA sponge targeting miR-20a and stable expression in Jurkat leukemia cell line Zhongguo shi yan xue ye xue za zhi /Zhongguo bing li sheng li xue hui = Journal of Experimental Hematology/Chinese Association of Pathophysiology 20 2012 1056 1062
152. J. Kluiver, I. Slezak-Prochazka, K. Smigielska-Czepiel, N. Halsema, B.J. Kroesen, and A. van den Berg Generation of miRNA sponge constructs Methods 58 2012 113 117